Referring Physicians

Streamlined IV iron referrals with specialist oversight, rapid access, and no infusion fee for your patients.

How to Refer

Three easy ways to submit a referral. Include patient demographics, recent labs, and relevant clinical history.

Preferred
Online Form (Preferred)

Secure, encrypted online submission via our referral form below.

Submit Online ↓
Email
Email

Send completed referral form and supporting documents to our secure email.

Admin@heme-iron-infusion.ca
Fax
Fax

Download the referral form below and fax to our referral fax line.

Fax: 604-398-8265

Online Referral Form

All data is encrypted in transit. Do not submit emergency referrals via this form.

🔒 This form is encrypted and transmitted securely. For urgent referrals call 604-332-7988.
Patient Information
Diagnostic Indication
Recent Laboratory Values (within last 3 months)
Date of test
Date of test
Date of test
Allergy & Safety History
Referring Physician

Target: Initial consultation + infusion typically within 2-3 weeks of a complete referral.

When to Refer

Documented iron deficiency on iron studies even if hemoglobin is normal, in patients with cardiac failure.
Patients experiencing any of the following symptoms:
  • Fatigue or low energy
  • Dyspnea on exertion
  • Restless legs syndrome
  • Hair shedding / hair loss
  • Pica (craving non-food substances)
Patients at high risk requiring rapid replenishment:
  • Pregnancy (2nd or 3rd trimester)
  • Postpartum state
  • Heavy menstrual bleeding (HMB)
  • Gastrointestinal blood loss
  • Post-surgical iron deficiency
  • Inflammatory bowel disease (IBD)
  • Chronic kidney disease (CKD)
IV iron is indicated when oral iron is:
  • Poorly tolerated (GI side effects)
  • Ineffective due to malabsorption (e.g., IBD, post-bariatric surgery)
  • Insufficient to meet needs with rapid or ongoing blood loss

Biochemical Thresholds

Include labs within the last 3 months with your referral.

ScenarioThreshold
General iron deficiencyFerritin < 30 µg/L
Inflammation / chronic disease / CKDFerritin < 100 µg/L & TSAT < 20%
Absolute iron deficiencyTSAT < 20% + low ferritin

Minimum Labs Required

(Within last 3 months, include dates)

  • CBC and Ferritin
  • TSAT, Transferrin Saturation (especially if inflammation/infection present)

What Happens Next

We keep the process simple so your patients receive care quickly.

1
Referral Reviewed by Hematologist

Specialist reviews eligibility, labs, and clinical indication. Incomplete referrals may be returned for additional information.

2
Patient Contacted for Telehealth Consultation

Patient receives a secure booking link to schedule their virtual consultation with the hematologist at their preferred date and time.

3
Eligibility Confirmed & Dosing Planned

Hematologist confirms eligibility and determines the iron dose. Prescription is sent to Pharmasave pharmacy, patients do not need to pick up medication.

4
Pharmacy Confirmation & IV Iron Shipped to Clinic

Pharmasave contacts the patient to confirm demographics and insurance. IV iron is shipped directly to the clinic.

5
Infusion Appointment, Within 2-3 Weeks

Patient attends a single-visit IV iron infusion. Ferinject administered in 15 minutes, brief monitored observation, discharge same day.

6
Follow-Up & Lab Monitoring

Post-infusion assessment to evaluate tolerability and response, with laboratory monitoring confirming iron repletion.

About Ferinject (Ferric Carboxymaltose)

Our primary iron formulation, high-dose, rapid, and extensively studied.

Clinical Profile

  • High-dose IV iron given in a single 15-minute infusion
  • Available globally for 18+ years; recently arrived in Canada
  • Studied in pregnant women, pediatrics (age 1+), renal disease, heart failure, IBD, IDA
  • Manufactured by CSL (also maker of iron sucrose / Venofer)
  • 30+ million patients/year experience worldwide

💳 Patient Benefit Program

Ferinject has a Patient Benefit Program providing financial support. Most insurance plans cover Ferinject. Pharmasave Pharmacy manages patient benefit cards, insurance claims, and co-pay assistance.

The clinic does not charge for the infusion.

Studied Populations

✓ Pregnant women
✓ Pediatrics (age 1+)
✓ Renal disease (CKD)
✓ Heart failure
✓ Inflammatory bowel disease
✓ Iron deficiency anemia
ⓘ Other formulations, including Monoferric and Iron Sucrose, may be used where clinically appropriate. The hematologist selects the optimal formulation at consultation.